Special Issue "Diabetes, Obesity and Metabolic Disease"

A special issue of Metabolites (ISSN 2218-1989). This special issue belongs to the section "Pharmacology and Drug Metabolism".

Deadline for manuscript submissions: 30 September 2023 | Viewed by 76

Special Issue Editor

Associate Professor, School of Medico Legal Studies, National Forensic Sciences University, Gandhinagar, Gujarat, India
Interests: metabolic abnormalities in cancer, cachexia and cardiovascular diseases

Special Issue Information

Dear Colleagues,

Metabolic disease is a cluster of diseases which occur due to alterations in various metabolic processes of our body due to abnormal biochemical reactions. There could be alterations in carbohydrate, protein, and/or lipid metabolism hampering overall functions of the body. Certain metabolic diseases include (but are not limited to) type 2 diabetes mellitus, obesity, metabolic syndrome, non-alcoholic fatty liver disease (NAFLD) etc. During advanced stages of cancer, cachexia starts developing which also involves altered carbohydrate and lipid metabolism. Such diseases make patients prone to other diseases, including cardiovascular diseases. This Special Issue will familiarize readers with molecular mechanisms of various metabolic diseases and approaches for pharmacological treatment of metabolic diseases. We therefore invite research/review papers focusing on any metabolic disease. We also aim to bring into the limelight any strategies to curb diseases such as obesity, type 2 diabetes, and NAFLD.

Dr. Bhoomika Patel
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Metabolites is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • type 2 diabetes mellitus
  • obesity
  • metabolic syndrome
  • non-alcoholic fatty liver disease (NAFLD)
  • syndrome X
  • cancer cachexia
  • cardiovascular diseases
  • insulin resistance

Published Papers

This special issue is now open for submission.
Back to TopTop